Silicon Carbide Biotechnology: A Biocompatible Semiconductor for Advanced Biomedical Devices and Applications. Este artículo no está disponible.Silicon Carbide Biotechnology: A Biocompatible Semiconductor for Advanced Biomedical Devices and Applications

Silicon Carbide Biotechnology: A Biocompatible Semiconductor for Advanced Biomedical Devices and Applications, Second Edition, provides the latest information on this wide-band-gap semiconductor material that the body does not reject as a foreign (i.e., not organic) material and its potential to further advance biomedical applications.

SiC devices offer high power densities and low energy losses, enabling lighter, more compact, and higher efficiency products for biocompatible and long-term in vivo applications, including heart stent coatings, bone implant scaffolds, neurological implants and sensors, glucose sensors, brain-machine-interface devices, smart bone implants, and organ implants.

This book provides the materials and biomedical engineering communities with a seminal reference book on SiC for developing technology, and is a resource for practitioners eager to identify and implement advanced engineering solutions to their everyday medical problems for which they currently lack long-term, cost-effective solutions.

• Discusses the properties, processing, characterization, and application of silicon carbide biomedical materials and related technology
• Assesses literature, patents, and FDA approvals for clinical trials, enabling rapid assimilation of data from current disparate sources and promoting the transition from technology R&D, to clinical trials
• Includes more on applications and devices, such as SiC nanowires, biofunctionalized devices, micro-electrode arrays, heart stent/cardiovascular coatings, and continuous glucose sensors, in this new edition

Dr. Stephen E. Saddow is currently a Professor of Electrical Engineering and Medical Engineering, both departments in the College of Engineering at the University of South Florida (USF), Tampa. In 2020, he was appointed as a visiting researcher in the Molecular Imaging Branch, National Cancer Institute, Bethesda, MD to facilitate the development of SiC-based nanoparticles to treat deep tissue cancer using near-infrared photoimmunotherapy (NIR-PIT). He is also a visiting scientist in the Elettra synchrotron light source in Trieste, Italy (BEAR beamline). He was elected Fellow of the AIMBE and is a senior member of both the IEEE and National Academy of Inventors. His group has demonstrated the compatibility of SiC and graphene to numerous cell lines in vitro and to the central nervous system of wild-type mice to cubic SiC (3C-SiC) in vivo. Studies include the MRI compatibility of 3C-SiC for neural probe applications as well as the ability to noninvasively detect changes in patient glucose levels without the need of needles that require frequent swap-out. The hemocompatibility of 3C-SiC has been established leading to the demonstration that 3C-SiC passed all phases of ISO-10993 testing, which is necessary to secure FDA approval for human clinical trials. He holds several patents relating to SiC biomedical devices, such as implantable glucose sensors and neural implants. He has more than 150 publications on SiC materials and devices and has edited two books on this topic: 'Silicon Carbide Biotechnology: A Biocompatible Semiconductor for Advanced Biomedical Devices and Applications' (Elsevier, 2012) and 'Silicon Carbide Biotechnology: A Biocompatible Semiconductor for Advanced Biomedical Devices and Applications, Second Edition' (Elsevier, 2016). His research interests include the development of advanced biomedical devices for human healthcare applications where he works at the nexus of material and biological science to engineer long-term, in vivo medical devices based on silicon carbide and its derivatives.